Beluga whale at Shedd Aquarium becomes first in the world to recover from general anesthesia after successful surgery
The 12-year-old whale named Kimalu needed to have a network of growing cysts on her head and neck near her blowhole removed. The team at the aquarium performed the historic surgery with Kimalu under general anesthesia.
Shedd officials said the surgery was a success, providing Kimalu with immediate relief, and she woke up from the anesthesia and is now recovering. She is being monitored around the clock during her recovery, focusing on antibiotics, incision site care, pain management and post-surgery nutrition.
Scientists say general anesthesia is particularly complicated for beluga whales because of their size and unique physiology. When she woke up, her lifelong caregivers were with her to speak to her and play recordings of vocalizations from the Shedd's beluga pod for her.
She is now recovering in a specially designed medical habitat.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
These two cancer drugs may help lower your risk of Alzheimer's disease, study shows
Scientists have identified two cancer drugs that may also lower the risk of Alzheimer's disease as they search for some way to lower its impact on an aging population. In a study published on Monday in the medical journal Cell, researchers from the University of California, San Francisco, combed through more than 1,300 candidate drugs — from antipsychotics to antibiotics — for anything that could help alleviate the incurable condition. Only 90 of those drugs targeted the brain cell genes thought to influence Alzheimer's, and of those only five showed evidence of actually reducing the risk of Alzheimer's in human patients. The scientists then chose letrozole, designed to fight breast cancer, and irinotecan, intended for treating colon and lung cancer, to test on mice. 'We didn't expect cancer drugs to come up," study co-author Marina Sirota told NBC News. In fact, the two drugs used in combination did appear to improve memory and brain function in aging mice who had begun to show signs of dementia. The effects still need to be proven in human studies (PA Wire) That result still needs to be tested in humans, and the drugs may prove less effective in humans. Still, the finding is significant because pharmaceutical companies have so far struggled to develop purpose-built drugs for the disease. "Developing a new drug can take hundreds of millions, or even billions, of dollars, on average take more than ten years," said study co-author Dr. Yadong Huang. "For this repurposed drug, usually it just takes two or three years, and then you can go to the clinical trial and the cost is much, much lower. "We still haven't generated or produced any very effective drugs that can really slow dramatically the cognitive decline," he added. Over seven million Americans live with Alzheimer's disease, according to the Alzheimer's Association, including 1 in 9 people aged over 65. The number is only likely to grow as the average age of the U.S. population continues to climb, with care costs for people with dementia projected to grow from $384 billion in 2025 to nearly $1 trillion by 2050.
Yahoo
an hour ago
- Yahoo
Florida's latest theme park injury report includes Universal's Epic Universe for first time
Florida's latest quarterly report on theme park injuries now includes Universal's Epic Universe for the first time. Since opening on May 22, Universal's Epic Universe has documented three incidents: two involving dizziness or numbness on the Stardust Racers ride, both in individuals with pre-existing conditions, and one case of chest pain on the Hiccups Wing Gliders ride. The report also discusses other major theme parks in Florida, in addition to the incidents at Epic Universe. Between April and July, Disney documented three incidents across its parks, whereas SeaWorld reported two incidents. According to the data provided, none of the injuries reported in the latest quarterly report were deemed serious. Click here to download our free news, weather and smart TV apps. And click here to stream Channel 9 Eyewitness News live. Solve the daily Crossword
Yahoo
2 hours ago
- Yahoo
AstraZeneca to invest $50 bln in US as pharma tariffs loom
STORY: AstraZeneca plans to invest $50 billion in the U.S. by 2030. The Anglo-Swedish drugs giant said Monday (July 21) that the money will fund a new factory in Virginia, and expand other facilities in states including California. It's the latest big player to make a move as Donald Trump's threat of tariffs hangs over the pharmaceutical industry. He's also pushing companies to make more of their products in the U.S. And he wants American drug costs to fall to levels seen elsewhere in the world. Announcing the investment plans, AstraZeneca chief Pascal Soriot said prices did need to equalize. He said drug charges elsewhere would need to rise, so that other countries contribute more to research and development costs. Exactly what Trump plans on tariffs remains unclear. ::July 15, 2025 "Pharmaceuticals will be tariffed, probably at the end of the month." He's repeatedly threatened to impose duties on the sector, but has also said that firms will be allowed up to 18 months to 'get their act together'. In a statement issued by the company, Commerce Secretary Howard Lutnick said Trump's tariffs will end America's long reliance on imported medicines. AstraZeneca's investment follows similar moves by European rivals like Roche, Sanofi and Novartis. U.S. players including Eli Lilly have also stepped up domestic spending. AstraZeneca says its plan will create tens of thousands of new jobs, without giving a specific number. Sign in to access your portfolio
